XML 45 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Borrowings (Details) - EUR (€)
€ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 10, 2018
Disclosure of detailed information about borrowings [line items]        
Total borrowings € 6,479   € 6,771  
Current portion (2,576)   (2,500)  
Non Current portion 3,903   4,271  
Result on derecognition of financial liabilities 408      
Innovation credit        
Disclosure of detailed information about borrowings [line items]        
Accrued interest 1,133   1,035  
Total borrowings € 3,907   3,907  
Notional amount       € 3,907
Interest rate (as percent) 10.00%      
Convertible loans        
Disclosure of detailed information about borrowings [line items]        
Accrued interest € 372   460  
Total borrowings € 1,067   € 1,369  
Convertible loans | Minimum        
Disclosure of detailed information about borrowings [line items]        
Period upon which unconverted loans become payable on demand 24 months      
Convertible loans Amylon Therapeutics B.V. [Member]        
Disclosure of detailed information about borrowings [line items]        
Interest rate (as percent) 8.00%      
Debt instrument convertible term 36 months      
Loan and interest waived € 408 € 0    
Convertible loans Amylon Therapeutics B.V. [Member] | Maximum        
Disclosure of detailed information about borrowings [line items]        
Period upon which unconverted loans become payable on demand 36 months